Cognitive deficits associated with cancer: A model of subjective and objective outcomes

Psychology, Health and Medicine

Volumn 10, Issue 2, 2005, Pages 145-160

  Green, Heather J ^a,b   Pakenham, Kenneth I ^c   Gardiner, Robert A ^c  

^a Inner North Brisbane Mental Health Service   (Australia)

^b CNRS   (France)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cancer; Cognition; Memory; Quality of life; Subjective

Indexed keywords

CYPROTERONE ACETATE; FLUTAMIDE; GOSERELIN; LEUPRORELIN;

BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PRACTICE; COGNITION; COGNITIVE DEFECT; COPING BEHAVIOR; EMOTION; HUMAN; MEMORY; NEUROTOXICITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; SOCIAL PSYCHOLOGY;

EID: 18644367421     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548500500093308     Document Type: Review

References (108)

1. Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., & Silberfarb, P. M. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
2. Alberts, D. S., & Noel, J. K. (1995). Cisplatin-associated neurotoxicity: Can it be prevented? Anti-Cancer Drugs, 6, 369-383.
3. Anderson-Hanley, C., Sherman, M. L., Riggs, R., Agocha, V. B., & Compas, B. E. (2003). Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the International Neuropsychological Society, JINS, 9, 967-982.
4. Antikainen, R., Hanninen, T., Honkalampi, K., Hintikka, J., Koivumaa-Honkanen, H., Tanskanen, A., & Viinamaki, H. (2001). Mood improvement reduces memory complaints in depressed patients. European Archives of Psychiatry and Clinical Neuroscience, 251, 6-11.
5. Armstrong, C. L., Gyato, K., Awadalla, A. W., Lustig, R., & Tochner, Z. A. (2004). A critical review of the clinical effects of therapeutic irradiation damage to the brain: The roots of controversy. Neuropsychology review, 14, 65-86.
6. Armstrong, C. L., Stern, C. H., & Corn, B. W. (2001). Memory performance used to detect radiation effects on cognitive functioning. Applied Neuropsychology, 8, 129-139.
7. Baker, S. C., Frith, C. D., & Dolan, R. J. (1997). The interaction between mood and cognitive function studied with PET. Psychological Medicine, 27, 565-578.
8. Benesch, M., Lackner, H., Schagerl, S., Gallistl, S., Frey, E. M., & Urban, C. (2001). Tumor- and treatment-related side effects after multimodal therapy of childhood intracranial germ cell tumors. Acta Paediatrica, 90, 264-270.
9. Bennett-Levy, J., & Powell, G. E. (1980). The Subjective Memory Questionnaire (SMQ). An investigation into the self-reporting of "real-life" memory skills. British Journal of Social and Clinical Psychology, 19, 177-188.
10. Bowling, A. (1991). Measuring health: A review of quality of life measurement scales. Buckingham: Open University Press.
11. Boyle, D. M., Abernathy, G., Baker, L., & Wall, A. C. (1998). End-of-life confusion in patients with cancer. Oncology Nursing Forum, 25, 1335-1343.
12. Breitbart, W., Rosenfeld, B., Roth, A., Smith, M. J., Cohen, K., & Passik, S. (1997). The Memorial Delirium Assessment Scale. Journal of Pain and Symptom Management, 13, 128-137.
13. Brickman, A. L., Yount, S. E., Blaney, N. T., Rothberg, S., & Kaplan De-Nour, A. (1996). Pathogenesis of cognitive complaints in patients on hemodialysis. General Hospital Psychiatry, 18, 36-43.
14. Broadbent, D. E., Cooper, P. F., Fitzgerald, P., & Parkes, K. R. (1982). The Cognitive Failures Questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology, 21, 1-16.
15. Bruera, E., Miller, L., McCallion, J., Macmillan, K., Krefting, L., & Hanson, J. (1992). Cognitive failure in patients with terminal cancer: A prospective study. Journal of Pain and Symptom Management, 7, 192-195.
16. Butler, R. W., & Copeland, D. R. (2002). Attentional processes and their remediation in children treated for cancer: A literature review and the development of a therapeutic approach. Journal of the International Neuropsychological Society, 8, 115-124.
17. Capuron, L., Ravaud, A., & Dantzer, R. (2001). Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosomatic Medicine, 63, 376-386.
18. Challinor, J., Miaskowski, C., Moore, I., Slaughter, R., & Franck, L. (2000). Review of research studies that evaluated the impact of treatment for childhood cancers on neurocognition and behavioral and social competence: Nursing implications. Journal of the Society of Pediatric Nurses, 5, 57-74.
19. Chen, E., Zeltzer, L. K., Bender, P. M., Byrne, J., Nicholson, H. S., Meadows, A. T., Mills, J. L., Haupt, R., Fears, T. R., & Robison, L. L. (1998). Pathways linking treatment intensity and psychosocial outcomes among adult survivors of childhood leukemia. Journal of Health Psychology, 3, 23-38.
20. Cherrier, M. M., Rose, A. L., & Higano, C. (2003). The effects of combined androgen blockade on cognitive function during the first cycle of interminent androgen suppression in patients with prostate cancer. Journal of Urology, 170, 1808-1811.
21. Christensen, H., Griffiths, K., Mackinnon, A., & Jacomb, P. (1997). A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. Journal of the International Neuropsychological Society, 3, 631-651.
22. Cimprich, B. (1998). Age and extent of surgery affect attention in women treated for breast cancer. Research in Nursing and Health, 21, 229-238.
23. Ciompi, L. (1991). Affects as central organising and integrating factors: A new psychosocial/biological model of the psyche. British Journal of Psychiatry, 159, 97-105.
24. Clarnette, R. M., Almeida, O. P., Forstl, H., Paton, A., & Martins, R. N. (2001). Clinical characteristics of individuals with subjective memory loss in Western Australia: Results from a cross-sectional survey. International Journal of Geriatric Psychiatry, 16, 168-174.
25. Cousens, P., Waters, B., Said, J., & Stevens, M. (1938). Cognitive effects of cranial irradiation in leukaemia: A survey and meta-analysis. Journal of Child Psychology and Psychiatry and Allied Disciplines, 29, 839-852.
26. Cull, A. (1990). Invited review: Psychological aspects of cancer and chemotherapy. Journal of Psychosomatic Research, 34, 129-140.
27. Cull, A., Hay, C., Love, S. B., Mackie, M., Smets, E., & Stewart, M. (1996). What do cancer patients mean when they complain of concentration and memory problems? British Journal of Cancer, 74, 1674-1679.
28. De Groot, J. C., De Leeuw, F. E., Oudkerk, M., Hofinan, A., Jolles, J., & Breteler, M. M. (2001). Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study. Neurology, 56, 1539-1545.
29. Derouesne, C., Lacomblez, L., Thibault, S., & Leponcin, M. (1999). Memory complaints in young and elderly subjects. International Journal of Geriatric Psychiatry, 14, 291-301.
30. Eiser, C. (1998). Practitioner review: Long-term consequences of childhood cancer. Journal of Child Psychology and Psychiatry, 39, 621-633.
31. Emskoetter, T., & Lachenmayer, L. (1990). The susceptibility of the central nervous system to open heart surgery. In A. E. Willner & G. Rodewald (Eds.), Impact of cardiac surgery on the quality of life: Neurological and psychological aspects (pp. 97-104). New York: Plenum Press.
32. Payers, P., Aaronson, N., Bjordal, K., & Sullivan, M. (1997). EORTC QLQ-C30 scoring manual (revised). Brussels: EORTC Study Group on Quality of Life.
33. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-Mental State: A practical method for grading the cognitive status of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
34. Goldstein, M. Z., Fogel, B. S., & Young, B. L. (1996). Effect of elective surgery under general anesthesia on mental status variables in elderly women and men: 10-month followup. International Psychogeriatrics, 8, 135-149.
35. Green, H. J., Pakenham, K. I., Headley, B. C., Yaxley, J., Nicol, D. L., Mactaggart, P. N., Swanson, C., Watson, R. B., & Gardiner, R. A. (2002). Altered cognitive function in men treated for prostate cancer with LHRH analogues and cyproterone acetate: A randomised controlled trial. BJU International, 90, 427-432.
36. Green, H. J., Pakenham, K. I., Headley, B. C., Yaxdey, J., Nicol, D. L., MacTaggart, P. N., Swanson, C. E., Watson, R. B., & Gardiner, R. A. (2004). Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: A randomized controlled trial. BJU International, 93, 975-979.
37. Hambrecht, M., Lammertink, M., Klosterkotter, J., Matuschek, E., & Pukrop, R. (2002). Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic. British Journal of Psychiatry, 43 (Suppl), s30-s37.
38. Harder, H., Cornelissen, J. J., van Gool, A. R., Duivenvoorden, H. J., Eijkenboom, W. M. H., & van den Bent, M. J. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer, 95, 183-192.
39. Harrison, J., & Maguire, P. (1994). Predictors of psychiatric morbidity in cancer patients. British Journal of Psychiatry, 165, 593-598.
40. Herrmann, D. J., & Neisser, U. (1978). An inventory of everyday memory experiences. In M. M. Gruenberg, P. E. Morris & R. N. Sykes (Eds.), Practical aspects of memory (pp. 35-51). London: Academic.
41. Hughes, J. E. (1987). Psychological and social consequences of cancer. Cancer Surveys, 6, 455-475.
42. Iconomou, G., Mega, V., Koutras, A., Iconomou, A. V., & Kalofonos, H. P. (2004). Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer, 101, 404-411.
43. Iuvone, L., Mariotti, P., Colosimo, C., Guzzetta, F., Ruggiero, A., & Riccardi, R. (2002). Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia. Cancer, 95, 2562-2570.
44. Johnson, T., Monk, T., Rasmussen, L. S., Abildstrom, H., Houx, P., Korttila, K., Kuipers, H. M., Hanning, C. D., Siersma, V. D., Kristensen, D., Canet, J., Ibanaz, M. T., Moller, J. T., & ISPOCD2 Investigators. (2002). Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology, 96, 1351-1357.
45. Jungwirth, S., Fischer, P., Weissgram, S., Kirchmeyr, W., Bauer, P., & Tragl, K. H. (2004). Subjective memory complaints and objective memory impairment in the Vienna-Transdanube aging community. Journal of the American Geriatrics Society, 52, 263-268.
46. Kaleita, T. A. (2002). Central nervous system-directed therapy in the treatment of childhood acute lymphoblastic leukemia and studies of neurobehavioral outcome: Children's Cancer Group trials. Current Oncology Reports, 4, 131-141.
47. Kibiger, G., Kirsh, K. L., Wall, J. R., & Passik, S. D. (2003). My mind is as clear as it used to be: A pilot study illustrating the difficulties of employing a single-item subjective screen to detect cognitive impairment in outpatients with cancer. Journal of pain and symptom management, 26, 705-715.
48. Klein, M., Taphoorn, M. J., Heimans, J. J., van der Ploeg, H. M., Vandertop, W. P., Smit, E. F., Leenstra, S., Tulleken, C. A., Boogerd, W., Belderbos, J. S., Cleijne, W., & Aaronson, N. K. (2001). Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. Journal of Clinical Oncology, 19, 4037-4047.
49. Lamberty, G. J., & Bieliauskas, L. A. (1993). Distinguishing between depression and dementia in the elderly: A review of neuropsychological findings. Archives of Clinical Neuropsychology, 8, 149-170.
50. Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal and coping. New York: Springer Publishing.
51. Levine, P. M., Silberfarb, P. M., & Lipowski, Z. J. (1978). Mental disorders in cancer patients: A study of 100 psychiatric referrals. Cancer, 43, 1385-1391.
52. Lezak, M. D. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.
53. Licinio, J., Kling, M. A., & Hauser, P. (1998). Cytokines and brain function: Relevance to interferon-alpha-induced mood and cognitive changes. Seminars in Oncology, 25 (Suppl. 1), 30-38.
54. Lilja, A. M., Portin, R. I., Hamalainen, P. I., & Salminen, E. K. (2001). Short-term effects of radiotherapy on attention and memory performances in patients with brain tumors. Cancer, 91, 2361-2368.
55. Loehlin, J. C. (1992). Latent variable models: An introduction to factor, path, and structural analysis (2nd ed.). Hillsdale, NJ; London: Lawrence Erlbaum.
56. Luszcz, M. A., & Bryan, J. (1999). Toward understanding age-related memory loss in late adulthood. Gerontology, 45, 2-9.
57. Maor, Y., Olmer, L., & Mozes, B. (2001). The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients-the role of depression. Multiple Sclerosis, 7, 131-135.
58. Matotek, K., Saling, M. M., Gates, P., & Sedal, L. (2001). Subjective complaints, verbal fluency, and working memory in mild multiple sclerosis. Applied Neuropsychology, 8, 204-210.
59. McDougall JR, G. J. (2001). Memory improvement program for elderly cancer survivors. Geriatric Nursing, 22, 185-190.
60. Meyers, C. A. (2000). Neurocognitive dysfunction in cancer patients. Oncology, 14, 75-79.
61. Milisen, K., Abraham, I. L., & Broos, P. L. O. (1998). Postoperative variation in neurocognitive and functional status in elderly hip fracture patients. Journal of Advanced Nursing, 26, 59-67.
62. Mintzer, J., & Burns, A. (2000). Anticholinergic side-effects of drugs in elderly people. Journal of the Royal Society of Medicine, 93, 457-462.
63. Moller, J. T., Cluitmans, P., Rasmussen, L. S., Houx, P., Rasmussen, H., Canet, J., Rabbitt, P., Jolles, J., Larsen, K., Hanning, C. D., Langeron, O., Johnson, T., Lauven, P. M., Kristensen, P. A., Biedler, A., van Beem, H., Fradiakis, O., Silverstein, J. H., Beneken, J. E. W., Gravenstein, J. S., & The ISPOCD Investigators. (1998). Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study. Lancet, 351, 857-861.
64. Neelon, V. J., Champagne, M. T., Carlson, J. R., & Funk, S. G. (1996). The NEECHAM Confusion Scale: Construction, validation, and clinical testing. Nursing Research, 45, 324-330.
65. Noble, M., & Dietrich, J. (2002). Intersections between neurobiology and oncology: Tumor origin, treatment and repair of treatment-associated damage. Trends in Neurosciences, 25, 103-107.
66. Olin, J. J. (2001). Cognitive function after systemic therapy for breast cancer. Oncology, 15, 613-618.
67. Olson, J. D., Riedel, E., & Deangelis, L. M. (2000). Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology, 54, 1442-1448.
68. Ownsworth, T. L., & McFarland, K. (1999). Memory remediation in long-term acquired brain injury: Two approaches in diary training. Brain Injury, 13, 605-626.
69. Oxman, T. E., & Silberfarb, P. M. (1987). Psychiatric aspects of cancer in the aged. Cancer Surveys, 6, 511-520.
70. Pereira, M., Hanson, J., & Bruera, E. (1997). The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer, 79, 835-842.
71. Poppelreuter, M., Weis, J., Kulz, A. K., Tucha, O., Lange, K. W., & Bartsch, H. H. (2004). Cognitive dysfunction and subjective complaints of cancer patients. A cross-sectional study in a cancer rehabilitation centre. European Journal of Cancer, 40, 43-49.
72. Randolph, J. J., Arnett, P. A., & Higginson, C. I. (2001). Metamemory and tested cognitive functioning in multiple sclerosis. The Clinical Neuropsychologist, 15, 357-368.
73. Reeb, R. N., & Regan, J. M. (1998). Survivors of pediatric cancer: Cognitive sequelae. Journal of Psychological Practice, 4, 61-76.
74. Reitan, R. M., & Wolfson, D. (1997). Emotional disturbances and their interaction with neuropsychological deficits. Neuropsychology Review, 7, 3-19.
75. Riedel, W. J., & Jolles, J. (1996). Cognition enhancers in age-related cognitive decline. Drugs and Aging, 8, 245-274.
76. Rozans, M., Dreisbach, A., Lertora, J. J., & Kahn, M. J. (2002). Palliative uses of methylphenidate in patients with cancer: A review. Journal of Clinical Oncology, 20, 335-339.
77. Sabbioni, M. E. E. (1991). Cancer and stress: A possible role for psychoneuroimmunology in cancer research? In C. L. Cooper & M. Watson (Eds.), Cancer and stress: Psychological, biological and coping studies (pp. 3-26). Chichester: John Wiley and Sons.
78. Salminen, E., Portin, R., Korpela, J., Backman, H., Parvinen, L. M., Helenius, H., & Nurmi, M. (2003). Androgen deprivation and cognition in prostate cancer. British Journal of Cancer, 89, 971-976.
79. Schagen, S. B., Hamburger, H. L., Muller, M. J., Boogerd, W., & van Dam, F. S. (2001). Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. Journal of Neuro-Oncology, 51, 159-165.
80. Schagen, S. B., Muller, M. J., Boogerd, W., Rosenbrand, R. M., van Rhijn, D., Rodenhuis, S., & van Dam, F. S. (2002). Late effects of adjuvant chemotherapy on cognitive function: A follow-up study in breast cancer patients. Annals of Oncology, 13, 1387-1397.
81. Short, K., McCabe, M., & Tooley, G. (2002). Cognitive functioning in chronic fatigue syndrome and the role of depression, anxiety, and fatigue. Journal of Psychosomatic Research, 52, 475-483.
82. Siegler, I. C., & Vitaliano, P. P. (1998). Introduction to the special section: In search of a double paradigm. Health Psychology, 17, 483-485.
83. Silberfarb, P. M. (1983). Chemotherapy and cognitive defects in cancer patients. Annual Review of Medicine, 34, 35-46.
84. Silberfarb, P. M., & Bates, G. M. (1983). Psychiatric complications of multiple myeloma. American Journal of Psychiatry, 140, 788-789.
85. So, N. K., O'Neill, B. P., Frytak, S., Eagan, R. T., Earnest, F., & Lee, R. E. (1987). Delayed leukoencephalopathy in survivors with small cell lung cancer. Neurology, 37, 1198-1201.
86. Spreen, O., & Strauss, E. (1991). A compendium of neuropsychological tests: Administration, norms, and commentary. New York: Oxford University Press.
87. St John, P., & Montgomery, P. (2002). Are cognitively intact seniors with subjective memory loss more likely to develop dementia? International Journal of Geriatric Psychiatry, 17, 814-820.
88. Tannock, I. F., Ahles, T. A., Ganz, P. A., & van Dam, F. S. (2004). Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. Journal of Clinical Oncology. Official Journal of the American Society of Clinical Oncology, 22, 2233-2239.
89. Temoshok, L. (1987). Personality, coping style, emotion and cancer: Towards an integrative model. Cancer Surveys, 6.
90. Temoshok, L. (1991). An integrative model for studies in biopsychosocial oncology. In J. Ten Have-De Labije & H. Balner (Eds.), Coping with cancer and beyond: Cancer treatment and mental health (pp. 65-80). Amsterdam: Swets and Zeitlinger.
91. The Psychological Corporation. (1997). Wechsler Adult Intelligence Scale-Third edition; Wechsler Memory Scale-Third edition: Technical manual. San Antonio: The Psychological Corporation; Harcourt Brace and Company.
92. Thompson, C. A., Shanafelt, T. D., & Loprinzi, C. L. (2003). Andropause: Symptom management for prostate cancer patients treated with hormonal ablation. Oncologist, 8, 474-487.
93. Thompson, S. J., Leigh, L., Christensen, R., Xiong, X., Kun, L. E., Heideman, R. L., Reddick, W. E., Gajjar, A., Merchant, T., Fui, C. H., Hudson, M. M., & Mulhern, R. K. (2001). Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. Journal of Clinical Oncology, 19, 1802-1808.
94. Tierney, M. C., Szalai, J. P., Snow, G., & Fisher, R. H. (1996). The prediction of Alzheimer disease: The role of patient and informant perceptions of cognitive deficits. Archives of Neurology, 53, 423-427.
95. Troy, L., McFarland, K., Littman-Power, S., Kelly, B. J., Walpole, E. T., Wyld, D., & Thomson, D. (2000). Cisplatin-based therapy: A neurological and neuropsychological review. Psycho-Oncology, 9, 29-39.
96. Tune, L., Carr, S., Hoag, E., & Cooper, T. (1992). Anticholinergic effects of drugs commonly prescribed for the elderly: Potential means for assessing risk of delirium. American journal of psychiatry, 149, 1393-1394.
97. van Dam, F. S. A. M., Schagen, S. B., Muller, M. J., Boogerd, W., Wall, E., Fortuyn, M. E. D., & Rodenhuis, S. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218.
98. Varner, L. J., & Ellis, H. C. (1998). Cognitive activity and physiological arousal: Processes that mediate mood-congruent memory. Memory and Cognition, 26, 939-950.
99. Walker, L. G., Walker, M. B., Heys, S. D., Lolley, J., Wesnes, K., & Eremin, O. (1997). The psychological and psychiatric effects of rIL-2 therapy: A controlled clinical trial. Psycho-Oncology, 6, 290-301.
100. Wang, L., van Belle, G., Kukull, W. B., & Larson, E. B. (2002). Predictors of functional change: A longitudinal study of nondemented people aged 65 and older. Journal of the American Geriatrics Society, 50, 1525-1534.
101. Weitzner, M. A., & Meyers, C. A. (1997). Cognitive functioning and quality of life in malignant glioma patients: A review of the literature. Psycho-Oncology, 6, 169-177.
102. Wieneke, M. H., & Dienst, E. R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology, 4, 61-66.
103. Williams, M. A. (1991). Delirium/acute confusional states, evaluation devices in nursing. International Psychogeriatrics, 3, 301-308.
104. Wilson, B. A. (1997). Cognitive rehabilitation: How it is and how it might be. Journal of the International Neuropsychological Society, 3, 487-496.
105. Winqvist, S., Vainionpaa, L., Kokkonen, J., & Lanning, M. (2001). Cognitive functions of young adults who survived childhood cancer. Applied Neuropsychology, 8, 224-233.
106. Winter, K. A., & Kuiper, N. A. (1997). Individual differences in the experience of emotions. Clinical Psychology Review, 17, 791-821.
107. Wolkowitz, O. M., Reus, V. I., Canick, J., Levin, B., & Lupien, S. (1997). Glucocorticoid medication, memory and steroid psychosis in medical illness. In P. M. Moore & R. G. Lahita (Eds.), Neuropsychiatric manifestations of systemic lupus erythematosus (Vol. 823, pp. 81-96). New York: The New York Academy of Sciences.
108. Zelinski, E. M., Crimmins, E., Reynolds, S., & Seeman, T. (1998). Do medical conditions affect cognition in older adults? Health Psychology, 17, 504-512.